Get the Prostate Cancer Patient Guide as a digital download or free mailed copy.

Click here.

Asics Brings Out the Blue to Battle Against Prostate Cancer
ASICS America introduces new collection benefitting the Prostate Cancer Foundation


October 28, 2014ASICS America is again teaming up with the Prostate Cancer Foundation to expand their Accelerate Hope Collection™. Firmly committed to curing prostate cancer, the Prostate Cancer Foundation is the leading philanthropic organization funding and accelerating research for the disease globally. Featuring a variety of new ASICS products, all in the signature bold blue color. ASICS America continues to help fund research to fight this cancer. This collection rounds out the larger Accelerate Hope Collection™ for ASICS, which includes collections benefiting breast cancer and children’s cancer, through Right Action for Women and Cookies for Kids Cancer, respectively.

Prostate cancer is the most common cancer in American men, second only to skin cancer. In fact, about one in seven men will be diagnosed with prostate cancer at some point during their lifetime. For the last 21 years, the Prostate Cancer Foundation has worked tirelessly to find unique strategies for identifying and investing in the most promising research programs, generating life-saving results. The organization channels resources to the world’s top scientific minds—cutting through red tape and encouraging collaboration to speed breakthroughs. In the past four years, research supported by the Foundation has helped deliver six new FDA-approved medicines now reaching patients with advanced disease.

For the 2014 Prostate Cancer Collection, ASICS has created a series of specialty products, including a new take on the award winning GEL-Cumulus®, with the GEL-Cumulus® 16 BR which sports a bright blue camouflage pattern and a blue ribbon on the heel of the shoe and the Quick Lyte® Cushion Single Tab sock . A new addition to the collection this year is a Titled Spiral™ Tech Tee, the Floating Ribbons Tee™, the Paint My Heart™ Tech Tee and the PR™ Runbrief. For the month of November, ASICS will donate $10 for every pair sold of the GEL-Cumulus® 16 BR, $2 for every Tech Tee, $2 for every Floating Ribbons Tee™, $2 for every PR™ Runbrief, and $1 for every Quick Lyte® Cushion Single Tab to The Prostate Cancer Foundation with a minimum donation of $100,000 (up to $150,000). These specially marked products now available at retail stores nationwide and athttp://www.asicsamerica.com.

“To compliment and continue our efforts to fight cancer and raise awareness of this cause, we’re excited to once again help contribute to life saving research through our partnership with the Prostate Cancer Foundation,” commented Shannon Scott, Senior Director of Marketing Communications and Advertising at ASICS America. “This year, we’ve expanded our collection to include new pieces for both men and women to expand our reach, and we’re committed to increasing our donation for this worthy cause.”

Available throughout the month of November, items within the ASICS Prostate Cancer Awareness Collection benefitting the Prostate Cancer Foundation include:

  • GEL-Cumulus® 16 BR (MSRP $115) – The award-winning GEL-Cumulus® series just keeps getting better, with the sixteenth version sporting a new top-of-the line FluidRide® midsole and larger Rearfoot and Forefoot GEL® Cushioning units. This version is the lightest and most cushioned version of the GEL-Cumulus® series ever.
  • Titled Spiral™ Tech Tee (MSRP $32) – The ASICS spiral teamed with ribbons in blue share the hope that someday everyone can experience ASICS’ philosophy of a Sound Mind in a Sound Body.
  • Floating Ribbons™ Tee (MSRP $32) – The quick-dry tech tee becomes an inspiring message of hope with floating ribbons in blue.
  • Paint My Heart™ Tech Tee (MSRP $32) – This lightweight, quick-dry Tech tee with paint splattered hearts in blue share the love and hope with the Accelerate Hope™ Paint My Heart™ Tee.
  • PR™ Runbrief (MSRP $22) – The ASICS® PR™ Runbrief with blue ribbons will keep athletes inspired to keep running for the cause in lightweight, seamless chafe-free comfort.
  • Quick Lyte® Cushion Single Tab (MSRP $14) – An ASICS favorite, this sock offers lightweight cushioning in high impact areas and features a blue ribbon signifying ASICS support of prostate cancer awareness and research.

“We are grateful to ASICS for their support of life-saving prostate cancer research and are thrilled to join forces again this year to raise funds and awareness in the fight against this disease,” commented Jonathan W. Simons, MD, president and CEO of the Prostate Cancer Foundation. “Approximately every two minutes, another man is diagnosed with prostate cancer. We’re intensifying our efforts to deliver better treatments to men battling prostate cancer, and support from partners such as ASICS is crucial in furthering our success in this mission.”

The ASICS America Prostate Cancer Awareness Collection™ is the third and final collection in the brand’s 2014 Accelerate Hope Collection™. For the month of September, ASICS launched its Pediatric Cancer Awareness Collection™ benefiting Cookies for Kids’ Cancer. In October, ASICS released its Breast Cancer Awareness Collection™ to benefit Right Action for Women. For more information on ASICS America and the ASICS Accelerate Hope Collection™ please visit www.asicsamerica.com and follow the brand on Twitter at @ASICSAmerica.


Anima Sana In Corpore Sano, meaning “A Sound Mind in a Sound Body,” is an old Latin phrase from which ASICS is derived and the fundamental platform on which the brand still stands. The company was founded more than 60 years ago by Kihachiro Onitsuka and is now a leading designer and manufacturer of performance athletic shoes, apparel and accessories. For more information, visit www.asics.com.

About The Prostate Cancer Foundation

The Prostate Cancer Foundation (PCF) is the world’s leading philanthropic organization funding and accelerating prostate cancer research. Founded in 1993, PCF has raised more than $615 million and provided funding to more than 2,000 research programs at nearly 200 cancer centers and universities. The PCF global research enterprise now extends to 19 countries. PCF advocates for greater awareness of prostate cancer and more efficient investment of governmental research funds for transformational cancer research. Its efforts have helped produce a 20-fold increase in government funding for prostate cancer. More information about PCF can be found at www.pcf.org.